a public good project by the
Synthesis
Company
of California

© 2026

Soichiro Hozawa | doi.page

0 works0 citations0 h-index

Soichiro Hozawa

Hiroshima Prefectural Rehabilitation Center(JP)

Publications by Year

Research Areas

Asthma and respiratory diseases, Respiratory and Cough-Related Research, Inhalation and Respiratory Drug Delivery, Drug-Induced Adverse Reactions, Chronic Obstructive Pulmonary Disease (COPD) Research

Most-Cited Works

→ Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids(2013)207 cited
→ Japanese guidelines for adult asthma 2020(2020)165 cited
→ Effects of a PAF Antagonist, Y-24180, on Bronchial Hyperresponsiveness in Patients With Asthma(1995)69 cited
→ Using Exhaled Nitric Oxide and Serum Periostin as a Composite Marker to Identify Severe/Steroid-Insensitive Asthma(2014)64 cited
→ Integrating longitudinal information on pulmonary function and inflammation using asthma phenotypes(2014)47 cited
→ GLCCI1 variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids(2014)45 cited

→ Asthma control and quality of life in a real-life setting: a cross-sectional study of adult asthma patients in Japan (ACQUIRE-2)(2018)

45 cited

→ Comparison of budesonide/formoterol Turbuhaler with fluticasone/salmeterol Diskus for treatment effects on small airway impairment and airway inflammation in patients with asthma(2011)42 cited

→ Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility(2019)38 cited

Increased expression of tumor necrosis factor-alpha, interleukin-6, platelet-derived growth factor-B and granulocyte-macrophage colony-stimulating factor mRNA in cells of bronchoalveolar lavage fluids from patients with sarcoidosis.(1996)